NEOGENOMICS INC
Provides precision oncology testing for cancer diagnostics, therapy guidance, and research.
NEO | NDAQ
Overview
Corporate Details
- ISIN(s):
- US64049M2098
- LEI:
- Country:
- United States of America
- Address:
- 9490 NEOGENOMICS WAY, 33912 FORT MYERS
- Website:
- https://neogenomics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
NeoGenomics, Inc. is a premier cancer diagnostics and genetics testing company focused on precision oncology. It provides a comprehensive menu of over 500 tests for solid tumors and hematologic cancers, utilizing advanced modalities such as next-generation sequencing (NGS), comprehensive genomic profiling (CGP), immunohistochemistry (IHC), FISH, and flow cytometry. The company delivers actionable diagnostic data, therapy guidance, and predictive biomarker insights through tissue-based and liquid biopsy solutions. NeoGenomics serves oncologists, pathologists, hospitals, and pharmaceutical companies, supporting personalized patient care and clinical research with a test menu that is regularly updated to align with the latest evidence and guidelines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NEOGENOMICS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NEOGENOMICS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NEOGENOMICS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
